A. Modesto

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Yungan Tao, J. Biau, X.S. Sun et al. · Annals of Oncology · 2022 · 166 citations · Full text

Ii Trial, Radiation Medicine, Radiation Therapy +10

Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination

A. Aboudaram, A. Modesto, Léonor Chaltiel et al. · Melanoma Research · 2017 · 97 citations

Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma

A. Modesto, Pierre Blanchard, Yungan Tao et al. · Oral Oncology · 2013 · 45 citations

Multimodal Treatment, Surgical Oncology, Interventional Neuroradiology +5

Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1

Aline Kowalski‐Chauvel, A. Modesto, Valérie Gouazé‐Andersson et al. · Cell Death and Disease · 2018 · 40 citations · Full text

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.

Jean Bourhis, Anne Aupérin, Christian Borel et al. · Journal of Clinical Oncology · 2025 · 36 citations

Surgical Oncology, Neoadjuvant Therapy, Lba2 Background +21